/BDX
Becton, Dickinson and Company
BDX • NYSEBDX • NYSE • Healthcare
$171.49-1.56%-2.72
$171.49-1.56%(-2.72)Healthcare
GoAI Score
Sign in to unlock
Valuation
50Fair Value
Sentiment
78Bullish
Risk
100Low Risk
Momentum
76Positive
Institutional-Grade Intelligence
🏆PRO
Actionable Intelligence
AI-driven stance, execution logic & risk thresholds
Catalyst Roadmap
Event timeline with expected impact & market context
Deep Insights
Fact-checked analysis & score logic breakdown
Financial Statements
Margin Trends
Gross
45.4%▲0.2pp
Revenue after COGS
Operating
11.8%▼0.1pp
After operating expenses
Net
7.7%▼0.8pp
Bottom-line profitability
Gross Margin
Operating Margin
Net Margin
Valuation Snapshot
P/E Ratio
19.8
Price vs earnings
EV/EBITDA
10.4
Enterprise value
FCF Yield
8.1%
Cash generation
Earnings Yield
5.1%
Inverse of P/E
Capital Efficiency
5
GoAI Quality ScoreWeak
ROEReturn on Equity
6.6%Fair
ROAReturn on Assets
3.0%Fair
ROICReturn on Invested Capital
4.7%Fair
Financial Health
Current RatioAdequate
1.11
Short-term solvency (>1.5)
Net Debt / EBITDAHigh
3.70x
Debt repayment capacity (<3x)
Income QualityStrong
2.04
Cash backs earnings (>1)
Revenue & Profitability
Revenue
Net Income
Net Loss
Income Statement
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $21.84B | $20.18B | $19.37B | $18.87B | $19.13B |
| Gross Profit | $9.92B | $9.13B | $8.17B | $8.48B | $8.63B |
| Gross Margin | 45.4% | 45.2% | 42.2% | 44.9% | 45.1% |
| Operating Income | $2.58B | $2.40B | $2.11B | $2.28B | $2.25B |
| Net Income | $1.68B | $1.71B | $1.48B | $1.78B | $2.09B |
| Net Margin | 7.7% | 8.4% | 7.7% | 9.4% | 10.9% |
| EPS | $5.84 | $5.88 | $4.97 | $5.93 | $6.92 |
Average Price Target
$193.80▲ 13.0% Upside
Past 12 Months
12 Month Forecast
Based on 50 Wall Street analysts offering 12 month price targets for Becton, Dickinson and Company, the average price target is $193.80, with a high forecast of $215.00 and a low forecast of $170.00. The average price target represents a 13.0% increase from the current price of $171.49.
Highest
$215.00
Average
$193.80
Lowest
$170.00
Rating Distribution
Strong Buy
0
0%
Buy
16
48%
Hold
16
48%
Sell
1
3%
Strong Sell
0
0%
Recent Analyst Ratings
FirmActionRatingDate
Citigroup● Maintain
Buy
2026-02-11Piper Sandler● Maintain
Neutral
2026-02-10Jefferies● Maintain
Buy
2026-02-10Wells Fargo● Maintain
Equal Weight
2026-02-10Citigroup● Maintain
Buy
2026-02-10JP Morgan● Maintain
Neutral
2026-02-10RBC Capital● Maintain
Sector Perform
2026-02-10Piper Sandler● Maintain
Neutral
2026-01-28Stifel● Maintain
Buy
2026-01-07B of A Securities● Maintain
Neutral
2026-01-05Earnings History & Surprises
BEAT RATE
94%
Last 18 quarters
AVG SURPRISE
+8.3%
EPS vs Estimate
BEATS / MISSES
17/0
1 met exactly
LATEST EPS
$2.91
Q1 '26
QUARTERLY EPS TREND
Estimated
Beat
Miss
QUARTERLY DETAIL
Q1 '26
+31.7%
$2.91 vs $2.21
Q4 '25
+1.0%
$3.96 vs $3.92
Q3 '25
+8.2%
$3.68 vs $3.40
Q2 '25
+2.1%
$3.35 vs $3.28
Q1 '25
+14.3%
$3.43 vs $3.00
Q4 '24
+1.1%
$3.81 vs $3.77
Q3 '24
+5.7%
$3.50 vs $3.31
Q2 '24
+6.7%
$3.17 vs $2.97
Q1 '24
+11.7%
$2.68 vs $2.40
Q4 '23
$3.42 vs $3.42
Q3 '23
+2.4%
$2.96 vs $2.89
Q2 '23
+4.0%
$2.86 vs $2.75
No investor questions available.
Latest News
No news available